Bioeconomical trends in modern medicine (literature review)

Abstract


Bioeconomics is not only a modern dynamically developing science, but also the main trend in the transformation of the economic space of any country. One of its priority areas is «red» biotechnology, reflecting the need to integrate scientific achievements in the field of biomedicine, personalized medicine, biopharmaceuticals, synthetic biology, and digital technologies into the healthcare sector. The analysis 58 of domestic and foreign scientific publications has shown the presence of a large number of innovative developments, the safe implementation of which in practice requires improving the issues of legal regulation of their use, developing mechanisms for integration not only into a specific branch of the economy, but also creating a logistical architecture for the use of resources «without remainder» in a single bioeconomic space. All this creates prerequisites for the development of integrated, interdisciplinary research aimed at developing organizational and managerial solutions aimed at implementing the basic principles of effective bioeconomics. In the field of medicine, in this regard, the science of public health and healthcare becomes the «leading violin», the methodological tools of which will allow solving the tasks posed by the challenges of modern healthcare in terms of integration and transformation into the bioeconomic course of state development.

About the authors

Evgeny L. Borshchuk

Orenburg State Medical University, Orenburg, Russia

Email: orgma.ru

Ekaterina V. Bulycheva

Email: bulucheva_yekaterina@list.ru

Dmitry N. Begun

Orenburg State Medical University, Orenburg, Russia

Email: doctorbegun@yandex.ru

Alexander B. Zudin

N. A. Semashko National Research Institute of Public Health, Moscow, Russian Federation

Email: zudin@nptemp.ru

References

  1. Gordeeva I. V. Bioeconomics as one of the strategic directions of sustainable development. Nauchnoe obozrenie. Jekonomicheskie nauki. 2019;(1):16–21.
  2. Hercik Yu. G. The main trends in the development of biomedical and biopharmaceutical technologies in bioeconomics. Remedium. 2022;(1):50–57.
  3. Zhiganova L. P. Modern innovative biotechnologies of the USA. Moskovskij jekonomicheskij zhurnal. 2019;(12):210–228.
  4. Herzik Yu. G. The importance and features of innovation marketing in the medical industry. Marketing v Rossii i za rubezhom. 2020;(4):79–86.
  5. Viaggi D., Zavalloni M. Bioeconomy and circular economy: implications for economic evaluation in the post-COVID era. Circ Econ. Sustain. 2021;1(4):1257–1269. doi: 10.1007/s43615-021-00113-1
  6. de Schutter L. Bioeconomy transitions through the lens of coupled social-ecological systems: a framework for place-based responsibility in the global resource system. Sustainability (Switzerland). 2019;11(20):5705. doi: 10.3390/su11205705
  7. Maksimtsev I. A., Suleymankadieva A. E., Fomicheva N. M. et al. Theory and practice of bioeconomics development: innovations, digitalization, transformation… St. Petersburg; 2019. 154 p. (In Russ.)
  8. Orekhov S. N., Yavorsky A. N. Bioeconomics and biosafety: In: Bioeconomics: doctrine, legislation, practice. monograph. Moscow, 2021:80–97. (In Russ.)
  9. Belyaeva A. A., Kolosov S. V. Prospects for the development of medical biotechnology. Bjulleten' Severnogo gosudarstvennogo medicinskogo universiteta. 2019;(1):294–95.
  10. Belyakova D. A., Dorokhina O. A., Kochukova A. A. Biotechnologies of the future in Russia. In: Modern directions of scientific research: materialy mezhdunarodnoj (zaochnoj) nauchno-prakticheskoj konferencii. Neftekamsk; 2023:7–11. (In Russ.)
  11. Dash S., Das T., Patel P. et al. Emerging trends in the nanomedicine applications of functionalized magnetic nanoparticles as novel therapies for acute and chronic diseases. J Nanobiotechnol. 2022;20(1):393. doi: 10.1186/s12951-022-01595-3
  12. Verma S. K., Panda P. K., Kumari P. et al. Determining factors for the nano-biocompatibility of cobalt oxide nanoparticles: proximal discrepancy in intrinsic atomic interactions at differential vicinage. Green Chem. 2021;23:3439–3458.
  13. Verma S. K., Jha E., Panda P. K. et al. Advanced nanostructured materials for environmental remediation. Biological effects of green-synthesized metal nanoparticles: a mechanistic view of antibacterial activity and cytotoxicity. Cham; 2019:145–171.
  14. Edomenko N. V. Technology of application of dermal fibroblasts as part of a biomedical cell product. In: Aktual'nye problemy biomediciny — 2022: Materialy XXVIII Vserossijskoj konferencii molodyh uchjonyh s mezhdunarodnym uchastiem. St. Petersburg; 2022:368–369. (In Russ.)
  15. Korovin A. E., Gorchichny V. A., Sokolova M. O., et al. Cell transplantation as one of the main directions of biomedical cell technologies. Klinicheskaja patofiziologija. 2019;25(2):13–20.
  16. Brightman V. I., Broitman N. Some results of treatment of patients with complications of diabetes mellitus using biomedical cell technologies. In: Fundamental'naja i klinicheskaja diabetologija v 21 veke: ot teorii k praktike: Sbornik tezisov konferencii po lecheniju i diagnostike saharnogo diabeta. Moscow; 2021:20–21. (In Russ.)
  17. Chernenko I. N., Plekhova N. G. Topical issues of the application of cellular technologies in practical healthcare in Russia. Vestnik «Biomedicina i Sociologija». 2021;6(1):30–36. doi: 10.26787/ny-dha-2618-8733- 2021-6-1-30-36
  18. Pestrikova A. A. Problems of formation of the regulatory and legal system in the field of genomic research (international legal aspect). In: Pravo i biznes: pravovoe prostranstvo dlja razvitija biznesa v Rossii: Kollektivnaja monografija. Moscow; 2020:126–135. (In Russ.)
  19. Kiryushina I. V., Mezentsev A. O. Biomedical law of Russia: the possibility of existence and prospects for development. Rossijsko-aziatskij pravovoj zhurnal. 2020;(1):18–22.
  20. Safronov Yu. N. Prospects and main directions of development of predictive, preventive and personalized medicine in the Russian Federation. Glavnyj vrach. 2021;(4):3–9.
  21. Berg L. N. Personalized medicine: legal and organizational foundations of medicine of the future. Lex Genetica. 2023;2(1):7–23. doi: 10.17803/lexgen-2023-2-1-7-23
  22. Chudakov S. Yu., Kuznetsov P. P., Galyamova M. R., Gostry A. V. Clinical practice in the field of personalized medicine in Russia: the legal field and the formation of quality standards. Menedzhment kachestva v medicine. 2019;(4):109–116.
  23. Zilov V. G., Carillo-Arkas A. H., Chudakov S. Yu., Kopeliovich G. B. Means and methods of traditional systems of the world in personalized medicine programs: legal basis and world experience. Terapevt. 2020;(1):58–65.
  24. Romanovsky G. B. Legal policy in the field of personalized medicine. Nauka. Obshhestvo. Gosudarstvo. 2020;8:1(29):54–62.
  25. Maglinova T. G. Digital technologies, digital revolution and digital economy: challenges and consequences. Estestvenno-gumanitarnye issledovanija. 2023;3(47):158–161.
  26. Shamshurina N. G. Social prospects of digitalization of healthcare: medical and sociological aspect. Sociologija mediciny. 2019;18(1):50–54. doi: 10.18821/1728-2810-2019-18-1-50-54
  27. Krutikov V. K., Kosogorova L. A., Yakunina M. V. et al. Driving forces of digital economy development in the medical field: cooperation on a global scale. Kreativnaja jekonomika. 2022;16(4):1535–1550.
  28. Abduganieva Sh.Kh., Juan R. D. S. Information in biomedicine. Universum: tehnicheskie nauki. 2023;9-2(114):35–37.
  29. Hesse B. W., Conroy D. E., Kwaśnicka D. et al. We're all in this together: recommendations from the Society of Behavioral Medicine's Open Science Working Group. Transl. Behav. Med. 2021;11(3):693–698. doi: 10.1093/tbm/ibaa126
  30. Wisniewski H., Gorrindo T., Rauseo-Ricupero N. et al. The role of digital navigators in promoting clinical care and technology integration into practice. Digit. Biomark. 2020;4(Suppl 1):119–135.
  31. Smith B., Magnani J. W. New technologies, new disparities: the intersection of electronic health and digital health literacy. Int. J. Cardiol. 2019;292:280–282.
  32. The Office of the National Coordinator for Health Information Technology. 2020–2025 Federal Health IT Strategic Plan. Washington; 2020. 46 p.
  33. Zheng C., Chen X., Weng L. Benefits of mobile apps for cancer pain management: Systematic review. JMIR Mhealth Uhealth. 2020;8(1):e17055
  34. Cadham C.J, Jayasekera J. C., Advani S. M. CISNET-SCALE Collaboration. Smoking cessation interventions for potential use in the lung cancer screening setting: a systematic review and meta-analysis. Lung Cancer. 2019;135:205–216.
  35. Cillessen L., Johannsen M., Speckens A. E.M., Zachariae R. Mindfulness-based interventions for psychological and physical health outcomes in cancer patients and survivors: A systematic review and meta-analysis of randomized controlled trials. Psychooncology. 2019;28(12):2257–2269.
  36. Kartskhiya A. A. Information and legal support of the digital ecosystem of healthcare. Pravovaja informatika. 2021;1:13–23.
  37. Gubernatorov A. M., Chirkov M. A., Chistyakov M. S., Zolkin A. L. The digital segment of medical care as a high-tech digital ecosystem of healthcare. In: Kljuchevye pozicii i tochki razvitija jekonomiki i promyshlennosti: nauka i praktika: Materialy II Mezhdunarodnoj nauchno-prakticheskoj konferencii. Lipetsk, 2022:153–157. (In Russ.)
  38. Kostenko E. G. Digital ecosystem in the field of healthcare. Prioritetnye nauchnye napravlenija 2024: Sbornik materialov XLVII mezhdunarodnoj ochno-zaochnoj nauchno-prakticheskoj konferencii. Moscow, 2024:137–139. (In Russ.)
  39. Dubovtsev Yu. A. Priorities of public health management in the context of the development of digital ecosystems. In: Tsifrovaja jekonomika i finansy: Materialy VII Mezhdunarodnoj nauchno-prakticheskoj konferencii. St. Petersburg, 2024:358–362. (In Russ.)
  40. Kiikova D. A. Business ecosystems and digitalization of healthcare. In: Al'manah nauchnyh rabot molodyh uchenyh Universiteta ITMO: Materialy Pjatidesjatoj nauchnoj i uchebno-metodicheskoj konferencii. Saint-Petersburg, 2021:223–226. (In Russ.)
  41. Burgonov O. V., Golubetskaya N. P. Promising directions for the formation of a digital healthcare ecosystem. In: Tsifrovaja jekonomika,umnye innovacii i tehnologii: Sbornik trudov Nacional'noj (Vserossijskoj) nauchno-prakticheskoj konferencii s zarubezhnym uchastiem. St. Petersburg, 2021:124–128. (In Russ.)
  42. Zubov E. V. The Unified health information system of the Perm Region as the digital basis of the ecosystem of public health protection in the region. In: Statistika zdravoohranenija novogo vremeni: Materialy Vtorogo s’ezda medicinskih statistikov Moskvy. Moscow; 2020:30–32. (In Russ.)
  43. Golubetskaya N. P., Burgonov O. V., Ushakova E. V. Formation of the ecosystem of regional healthcare in the digital economy. In: A. V. Babkin (ed.). Strategicheskoe upravlenie razvitiem cifrovoj jekonomiki na osnove umnyh tehnologij. St. Petersburg; 2021:201–221. (In Russ.)
  44. Sagadatova L. V. Digital ecosystem of healthcare in the Republic of Bashkortostan. In: Pokolenija Y i Z v postpandemijnoj real'nosti: identifikacii, orientacii, povedenie: Sbornik statej Vserossijskoj nauchno-prakticheskoj konferencii. Ufa; 2022:129–134. (In Russ.)
  45. Aksenova E. I., Gorbatov S. Yu. Application of 5G technologies in healthcare: how the new cellular standard is changing the industry ecosystem. Moscow; 2021. (In Russ.)
  46. Nikolaev V. A. Organization of tele-rehabilitation of stroke patients within the framework of the digital healthcare ecosystem. In: Menedzhment v zdravoohranenii: vyzovy i riski XXI veka: Sbornik materialov VI Mezhdunarodnoj nauchno-prakticheskoj konferencii. Volgograd; 2022:66–69. (In Russ.)
  47. Shamaev D. M., Zayats V. V., Orlov S. B. AI platforms and ecosystems in healthcare. In: Informacionnye tehnologii i nanotehnologii (ITNT-2023): Sbornik trudov po materialam IX Mezhdunarodnoj konferencii i molodezhnoj shkoly. Samara; 2023;4:42242. (In Russ.)
  48. Zima D. OT-solutions play a key role in the development of the digital health ecosystem. Quality management in medicine. 2024;2:2–4.
  49. Filimonov I. V. Health ecosystem as a form of organization for countering biological threats. In: Filosofsko-metodologicheskie osnovanija upravlenija obshhestvennym zdorov'em: razvitie zdravoohranenija v postpandemijnyj period: Materialy Shestoj ezhegodnoj nauchno-prakticheskoj konferencii. Moscow, 2023:66–74. (In Russ.)
  50. Holodnaya E. V. On promising areas of legal regulation in the field of artificial intelligence technology. Vestnik Universiteta imeni O. E. Kutafina (MGJuA). 2019;(12):89–96. doi: 10.17803/2311-5998.2019.64.12.089-096
  51. Titkov V. S. Legal regulation and prospects for the development of artificial intelligence in the field of medicine. In: Pravo i biznes: pravovoe prostranstvo dlja razvitija biznesa v Rossii. Moscow; 2020:355–361.
  52. Kavelina T. A., Sobyanin A. V., Marukhno V. M. On the issue of legal regulation of the use of artificial intelligence in medicine. Gumanitarnye, social'no-jekonomicheskie i obshhestvennye nauki. 2022;2:148–151.
  53. Nikitenko S. V. International legal regulation of the use of artificial intelligence in the field of medicine. Vestnik Volzhskogo universiteta im. V. N. Tatishheva. 2023;1(3):215–229.
  54. Minbaleev A. V., Titova E. V. Problems of legal regulation of the use of artificial intelligence in sports medicine. Chelovek. Sport. Medicina. 2024;24(S1):108–114.
  55. Korsakova I. I., Belousov A. M., Zhirkova I. N., Pimenova Yu. Yu., Shadrina S. V. Synthetic biology: potential risks and regulatory issues. In: Materialy XVI Mezhgosudarstvennoj nauchno-prakticheskoj konferencii po voprosam sanitarnoj ohrany territorii i snizhenija riska rasprostranenija chumy. Saratov; 2022: 97–98. (In Russ.)
  56. Li J., Zhao H., Zheng L., An W. Advances in synthetic biology and biosafety governance. Front. Bioeng. Biotechnol. 2021;9:598087. doi: 10.3389/fbioe.2021.598087
  57. Richardson L. C., Connell N. D., Lewis S. M., Pauwels E., Murch R. S. Cyberbiosecurity: a call for cooperation in a new threat landscape. Front. Bioeng. Biotechnol. 2019;7:99. doi: 10.3389/fbioe.2019.00099

Statistics

Views

Abstract - 0

PDF (Russian) - 0

Cited-By


PlumX

Dimensions


Copyright (c) 2024 АО "Шико"

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Mailing Address

Address: 105064, Moscow, st. Vorontsovo Pole, 12, building 1

Email: redactor@remedium-journal.ru

Phone: +7(495) 917-48-86



Principal Contact

Sherstneva Elena Vladimirovna
EXECUTIVE SECRETARY
FSSBI «N.A. Semashko National Research Institute of Public Health»

105064, Vorontsovo Pole st., 12, Moscow


Email: redactor@remedium-journal.ru

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies